C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2001
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/06/2001	CA2212449C Improved preparation of 1,2,5,6-tetrahydro-3-carboalkoxypyridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypyridines and arecoline hydrobromide
11/06/2001	CA2193178C Matrix metalloprotease inhibitors
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001	WO2001081343A2 Compounds for treating fibromyalgia and chronic fatigue syndrome
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001081309A2 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
11/01/2001	WO2001081308A2 Aminopiperidines for use as glyt-1 inhibitors
11/01/2001	WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010037027 Method for optical resolution of piperidine carboxylic acid derivative
11/01/2001	US20010037026 Reacting a protected amino acid ester with a 4-substituted butyric acid derivative, cyclizing the protected intermediate, benzylating and decarboxylating the intermediate, asymmetric hydrogenation using a catalyst
11/01/2001	US20010037023 Alkyl pyrimidines substituted piperidine derivatives are used as tachykinin antagonsit, useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorder, inflammation, and neurological disorders
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	CA2406652A1 Aminopiperidines for use as glyt-1 inhibitors
11/01/2001	CA2405565A1 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/2001
10/31/2001	EP1149832A1 Benzamide derivatives and drugs containing the same
10/31/2001	EP1149831A1 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP0828711B1 New process for the preparation of ropivacaine hydrochloride monohydrate
10/31/2001	EP0773929B1 Piperidine derivatives as neurokinin antagonists
10/31/2001	EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001	EP0688317B1 Process for preparing acryl-piperidine carbinols
10/31/2001	DE10008089A1 Production of tubulysin compounds comprises multi-stage process including condensation of N-methylpipecolinoyl-isoleucine with substituted thiazole-4-carboxylic acid derivative
10/31/2001	CN1320125A Trizolopyridines for the treamtent of thrombosis disorders
10/31/2001	CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001	CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001	CN1320036A Methods and compositions for treating gastro-esophageal reflux disease
10/31/2001	CN1320028A Method of treating hair loss using sulfonamides
10/31/2001	CN1319590A 2,2,6,6, diethyl-dimethy-1-alkoxy-piperidine compound and 1-oxide
10/30/2001	US6310246 Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
10/30/2001	US6310213 Good affitity to the nmda receptor and they are therefore useful in the treatment of neurodegenerative diseases
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310076 Dihydropyridines and new uses thereof
10/30/2001	US6310059 Constrained fused ring derivatives of piperidine or piperazine linked to hydrophobic substituents which enhance calcium channel blocking activity; combinatorial libraries for drug screening
10/30/2001	CA2113189C Diaminic compounds, preparation, use and intermediates
10/28/2001	CA2345846A1 Preparation process for n,n'-carbonylbis-lactams
10/25/2001	WO2001079204A1 Phenyl substituted 4-hydroxy tetrahydropyridone
10/25/2001	WO2001079199A1 Acetylene derivatives and herbicides containing the same
10/25/2001	WO2001079188A1 Antihistaminic compounds
10/25/2001	WO2001079171A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
10/25/2001	WO2001079170A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/25/2001	WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	US20010034451 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders
10/25/2001	US20010034449 Stabilizer for plastics
10/25/2001	US20010034369 Prevention, therapy thrombosis, restenosis
10/25/2001	US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001	DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/24/2001	EP1148050A1 Retroviral protease inhibitors
10/24/2001	EP1147085A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors / tnf-alpha converting enzyme (tace) inhibitors
10/24/2001	EP1147084A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1146871A1 Antidepressant heterocyclic compounds
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP0970050B1 Process for the preparation of 10,11-dihydro-5h-dibenzo a,d]cyclohept-5-enes and derivatives thereof
10/24/2001	EP0845013B1 Use of piperidine compounds
10/24/2001	EP0822933B1 Process for producing piperidinopentanamines
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319086A Anthranilic acid derivatives
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6306959 Rapid purification by polymer supported quench
10/23/2001	US6306882 Fluoroalkylpiperidine esters cognition activators and alzheimer's
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306595 Design of drugs involving receptor-ligand-DNA interactions
10/23/2001	CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001076599A1 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free base form
10/18/2001	WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001	WO2000035436A3 Treatment of arthritis with mek inhibitors
10/18/2001	US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001	US20010031872 For automobile finishes; heat, oxidation, radiation resistance
10/18/2001	US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001	US20010031767 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias
10/18/2001	DE10016379A1 Novel 4-Formylamino-N-methylpiperidine compounds are useful as stabilizers for polymers and lacquers and as light protection agents and stabilizers for wood surfaces
10/18/2001	CA2403012A1 Chemical compounds
10/17/2001	EP1146029A1 Method for optical resolution of piperidine carboxylic acid derivative
10/17/2001	EP1145715A2 Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
10/17/2001	EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144378A2 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetraalkylpyridines
10/17/2001	EP1144370A2 Thyroid receptor ligands
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144360A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
10/17/2001	EP1144066A1 Dehydration process
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143971A1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
10/17/2001	EP1143957A2 Treatment of arthritis with mek inhibitors
10/17/2001	EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001	EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/17/2001	EP0783491B1 Process for the preparation of 3,3,5-trichloroglutarimide

1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 380